{
  "case_id": "case_0018",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 39.18,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "East Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve (cranial nerve II).",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- MOG antibody\u2013associated optic neuritis; Aquaporin-4 NMOSD optic neuritis; Compressive optic neuropathy of the left optic nerve; Non-arteritic anterior ischaemic optic neuropathy; Sarcoid optic neuropathy; Syphilitic optic neuritis; Leber hereditary optic neuropathy; Toxic-nutritional optic neuropathy",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Demyelinating optic neuritis (multiple sclerosis\u2013associated)",
          "MOG antibody\u2013associated optic neuritis",
          "Aquaporin-4 NMOSD optic neuritis",
          "Compressive optic neuropathy of the left optic nerve",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Sarcoid optic neuropathy",
          "Syphilitic optic neuritis",
          "Leber hereditary optic neuropathy",
          "Toxic-nutritional optic neuropathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Tinnitus": "comorbidity",
          "Lactose intolerance": "comorbidity",
          "Hay fever": "comorbidity",
          "Astigmatism": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Tinnitus",
          "Lactose intolerance",
          "Hay fever",
          "Astigmatism"
        ],
        "additional_diagnoses": [
          "MOG antibody\u2013associated optic neuritis",
          "Aquaporin-4 NMOSD optic neuritis",
          "Compressive optic neuropathy of the left optic nerve",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Sarcoid optic neuropathy",
          "Syphilitic optic neuritis",
          "Leber hereditary optic neuropathy",
          "Toxic-nutritional optic neuropathy"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI orbits and brain with gadolinium and fat-suppressed sequences",
          "Automated perimetry (Humphrey visual field)",
          "Optical coherence tomography (retinal nerve fibre layer and macula)",
          "Visual evoked potentials",
          "Comprehensive ophthalmological examination with dilated fundoscopy",
          "Aquaporin-4 IgG (cell-based assay)",
          "MOG-IgG (cell-based assay)",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Thyroid function tests",
          "Vitamin B12",
          "Folate",
          "Serum ACE level",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "ANCA",
          "Syphilis serology (treponemal and non-treponemal tests)",
          "HIV antigen/antibody test",
          "Lyme disease serology",
          "Interferon-gamma release assay for tuberculosis",
          "MRI of cervical and thoracic spine with gadolinium",
          "Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands and IgG index"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 2,
        "found_tests_count": 2,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Typical unilateral optic neuritis pattern with left RAPD and reduced acuity",
              "Early high-dose steroids hasten visual recovery",
              "No systemic red flags for infection or sepsis",
              "MRI will be arranged urgently to exclude compression; benefits outweigh risks"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastroprotection",
            "timing": "Start Now",
            "reasons": [
              "Concomitant high-dose corticosteroid therapy",
              "Reduces risk of steroid-induced gastritis/ulcer"
            ]
          },
          {
            "treatment": "Oral prednisolone taper after IV pulse",
            "timing": "Delay",
            "reasons": [
              "Initiate only after IV methylprednisolone course",
              "Avoid oral steroid monotherapy which increases relapse risk in demyelinating optic neuritis"
            ]
          },
          {
            "treatment": "Therapeutic plasma exchange (5\u20137 exchanges)",
            "timing": "Delay",
            "reasons": [
              "Reserve for severe vision loss or failure to improve within 3\u20137 days of IV steroids",
              "Particularly effective in NMOSD/MOGAD"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for multiple sclerosis",
            "timing": "Delay",
            "reasons": [
              "Start only if MRI/CSF confirm MS",
              "Choice depends on risk profile and patient preference"
            ]
          },
          {
            "treatment": "Targeted therapy for NMOSD (e.g., rituximab or satralizumab)",
            "timing": "Delay",
            "reasons": [
              "Initiate only if AQP4-IgG positive or diagnostic criteria met",
              "Prevents relapses causing permanent vision loss"
            ]
          },
          {
            "treatment": "Pathogen-directed antimicrobial therapy if infectious optic neuritis confirmed",
            "timing": "Delay",
            "reasons": [
              "Avoid steroids alone in untreated infection",
              "Tailor to organism such as IV penicillin for syphilis or anti-tuberculous therapy for TB"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Typical unilateral optic neuritis pattern with left RAPD and reduced acuity",
              "Early high-dose steroids hasten visual recovery",
              "No systemic red flags for infection or sepsis",
              "MRI will be arranged urgently to exclude compression; benefits outweigh risks"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for multiple sclerosis",
            "timing": "Delay",
            "reasons": [
              "Start only if MRI/CSF confirm MS",
              "Choice depends on risk profile and patient preference"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.5,
          "proportion_reasons_missed": 0.5
        }
      }
    }
  }
}